| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |